Loading stock data…
Phreesia (PHR)
$10.22-0.72 (-6.58%)
Market ClosedLast close Sep 8
Phreesia, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Phreesia, Inc. in the Healthcare sector is trading at $10.22 with a market capitalization of $562M. Wall Street consensus targets $13.94 (16 analysts), implying a +36.4% move over the next 12 months. The stock is currently near its 52-week low of $7.77, remaining 16.6% below its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the distress zone. Risk note: MACD remains below its signal line. The Whystock Score of 50/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side targets imply +36.4% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Oversold momentum (RSI 35) — potential for technical mean-reversion
Quarterly Financials
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $130.94M↑ | $127.07M↑ | $120.33M↑ | $117.25M↑ | $115.94M |
| Gross Profit | $87.60M↑ | $86.68M↑ | $82.31M↑ | $79.61M↑ | $77.87M |
| Operating Income | $6.75M↑ | -$5.56M↓ | $3.74M↑ | -$1.51M↑ | -$3.29M |
| Net Income | $2.96M↑ | $1.29M↓ | $4.27M↑ | $654,000↑ | -$3.91M |
Peer Comparison
JNJUNHPFE
Fundamentals
Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. It offers solutions including appointment optimization and referral management using AI-enabled workflows; and...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$561.87M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
2.56%
Volume
Today's trading volume
882,060
Recent News
Why Phreesia Stock Got Knocked Down Today
An analyst's recommendation downgrade did the company few favors.
Why Phreesia Stock Tumbled Today
Its latest quarterly earnings were not greeted warmly by Mr. Market.
Phreesia, Inc. Q2 2027 Earnings Call Summary
Moby summary of Phreesia, Inc.'s Q2 2027 earnings call
Phreesia Inc (PHR) (Q2 2027) Earnings Call Highlights: Record EBITDA Margin and Strategic ...
Phreesia Inc (PHR) delivers 10% revenue growth and 25% adjusted EBITDA margin while expanding AccessOne and AI-driven Network Solutions.
Phreesia Q2 Earnings Call Highlights
Phreesia (NYSE:PHR) reported second-quarter fiscal 2027 revenue growth and continued profitability expansion, while maintaining its full-year revenue and adjusted EBITDA outlook. The company said it generated positive operating and free cash flow for the ninth consecutive quarter and used its cash g